Comparable stake leader
Valor BrainsWay Holdings, LLC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001505065.
Comparable stake leader
Valor BrainsWay Holdings, LLC
Disclosed value leader
Valor BrainsWay Holdings, LLC
Comparable rows
50/50
Latest evidence
30 Jun 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Valor BrainsWay Holdings, LLC |
13D/G
Jonathan Shulkin
|
15%
|
$88,184,187
5,851,444 shares
|
-$28,521,524 | 06 Oct 2025 |
| Harel Insurance Investments & Financial Services Ltd. |
13D/G
13F
Company
|
8.3%
|
$50,643,369
3,265,397 shares
|
+$9,123,693 | 30 Jun 2026 |
| MEITAV INVESTMENT HOUSE LTD |
13D/G
|
6.3%
|
$42,391,572
2,532,352 shares
|
+$7,243,649 | 01 Jun 2026 |
| Avner Hagai |
13D/G
|
4.7%
|
$16,784,164
1,772,351 shares
|
$0 | 28 Jan 2025 |
| Valor Management LLC |
13F
Company
|
14%
|
$82,434,875
5,314,950 shares
|
— | 30 Jun 2026 |
| MASTERS CAPITAL MANAGEMENT LLC |
13F
Company
|
3.8%
|
$23,265,000
1,500,000 shares
|
— | 30 Jun 2026 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
2.1%
|
$12,514,000
807,931 shares
|
— | 30 Jun 2026 |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
Company
|
1.5%
|
$9,191,319
592,606 shares
|
— | 30 Jun 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 19 Aug 2025.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-13 of 13 reporting-owner rows connected to Brainsway Ltd.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jonathan K. Shulkin | Director | Mixed | 18 Mar 2026 | |||
| Gilad Moiseyev | Chief Technology Officer | Mixed | 25 May 2026 | |||
| Amiram Boehm | Director | Mixed | 18 Mar 2026 | |||
| Colleen Hanlon | VP of Medical Affairs | Mixed | 18 Mar 2026 | |||
| Hadar Levy | Chief Executive Officer | Mixed | 18 Mar 2026 | |||
| Naomi Rozenfeld | Chief Marketing Officer | Mixed | 18 Mar 2026 | |||
| Avner Lushi | Director | Mixed | 18 Mar 2026 | |||
| Karen Sarid | Director | Mixed | 18 Mar 2026 | |||
| Ido Marom | Chief Financial Officer | Mixed | 18 Mar 2026 | |||
| Yiftach Roth | Chief Scientist | Mixed | 01 Jun 2026 | |||
| David Zacut | Director | Mixed | 18 Mar 2026 | |||
| Abraham Zangen | Director | Mixed | 18 Mar 2026 | |||
| Rayten Michal Ety Mitrany | Director | Mixed | 25 May 2026 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Gilad Moiseyev | BWAY | Ordinary Shares | Sale | -8.61% | -5,000 | 53,098 | 15 Jun 2026 | Direct | ||
| Yiftach Roth | BWAY | Ordinary Shares | Sale | -0.28% | -3,000 | 1,072,305 | 02 Jun 2026 | Direct | ||
| Yiftach Roth | BWAY | Ordinary Shares | Sale | -0.37% | -4,000 | 1,075,305 | 01 Jun 2026 | Direct | ||
| Rayten Michal Ety Mitrany | BWAY | Ordinary Shares | Sale | -39% | -7,980 | 12,500 | 26 May 2026 | Direct | ||
| Gilad Moiseyev | BWAY | Ordinary Shares | Tax liability | -3.17% | -1,902 | 58,098 | 25 May 2026 | Direct | ||
| Gilad Moiseyev | BWAY | Ordinary Shares | Options Exercise | 14.3% | 7,500 | 60,000 | 25 May 2026 | Direct | ||
| Gilad Moiseyev | BWAY | Stock Options (right to buy) | Options Exercise | -25% | -7,500 | 22,500 | 25 May 2026 | Direct | ||
| Rayten Michal Ety Mitrany | BWAY | Ordinary Shares | Sale | -32.8% | -10,000 | 20,480 | 25 May 2026 | Direct | ||
| Rayten Michal Ety Mitrany | BWAY | Ordinary Shares | Tax liability | -16.6% | -6,080 | 30,480 | 20 May 2026 | Direct | ||
| Rayten Michal Ety Mitrany | BWAY | Ordinary Shares | Options Exercise | 91.8% | 17,500 | 36,560 | 20 May 2026 | Direct | ||
| Rayten Michal Ety Mitrany | BWAY | Stock Options (right to buy) | Options Exercise | -100% | -17,500 | 0 | 20 May 2026 | Direct | ||
| Rayten Michal Ety Mitrany | BWAY | Ordinary Shares | Tax liability | -15.3% | -3,440 | 19,060 | 19 May 2026 | Direct | ||
| Rayten Michal Ety Mitrany | BWAY | Ordinary Shares | Options Exercise | 80% | 10,000 | 22,500 | 19 May 2026 | Direct | ||
| Rayten Michal Ety Mitrany | BWAY | Stock Options (right to buy) | Options Exercise | -36.4% | -10,000 | 17,500 | 19 May 2026 | Direct |